Strategic partnerships We Are Volume positions itself as a white-label digital production studio embedded inside creative and healthcare agencies, offering a scalable production solution without onboarding ramp or vendor overhead. This makes them an attractive partner for agencies facing capacity constraints who want to expand capabilities in display, email, pharma-compliant materials, and web assets under their own brand.

Pharma focus With pharma-compliant CLM and MLR materials from day one, plus a production system tuned for regulated content, there is a clear opportunity to target pharmaceutical marketing groups, medical affairs teams, and contract pharmaceutical agencies seeking compliant, fast-turnaround digital assets.

Production efficiency Their Production Operating System leverages AI agents to manage intake, estimation, scaffolding, visual QA, and delivery, enabling a 13-person studio to output at the level of a larger team. This efficiency angle can be a selling point to agencies looking to optimize cost and speed.

Capacity relief The company notes availability for 2–3 new studio relationships in 2026, signaling openness to new partnerships and potential for capacity-backed project wins for agencies experiencing near-term overflow in display, email, and web production.

Growth signals Revenue range of 10 to 25 million and a history of 15+ Cannes Lions over 15+ years establish credibility in high-quality creative production. This can be leveraged when engaging senior decision-makers at mid-to-large agencies seeking proven creative execution and award-winning capabilities.